D.E. Shaw & Co
SLDB icon

D.E. Shaw & Co’s Solid Biosciences SLDB Stock Holding History

D.E. Shaw & Co’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$924K Buy
128,348
+88
+0.1% +$565 ﹤0.01% 3493
2025
Q4 		$723K Buy
+128,260
New +$695K ﹤0.01% 3735
2025
Q1 		– Sell
-51,972
Closed -$208K – 4703
2024
Q4 		$208K Buy
+51,972
New +$285K ﹤0.01% 4068
2021
Q4 		– Sell
-1,312
Closed -$47K – 5689
2021
Q3 		$47K Sell
1,312
-3,227
-71% -$137K ﹤0.01% 4830
2021
Q2 		$249K Buy
4,539
+3,440
+313% +$227K ﹤0.01% 4359
2021
Q1 		$91K Sell
1,099
-13,992
-93% -$1.55M ﹤0.01% 3938
2020
Q4 		$1.72M Sell
15,091
-4,478
-23% -$283K ﹤0.01% 2650
2020
Q3 		$596K Sell
19,569
-4,326
-18% -$166K ﹤0.01% 3137
2020
Q2 		$1.05M Buy
23,895
+3,474
+17% +$144K ﹤0.01% 2895
2020
Q1 		$732K Buy
20,421
+2,787
+16% +$138K ﹤0.01% 2977
2019
Q4 		$1.18M Buy
17,634
+12,466
+241% +$1.38M ﹤0.01% 2871
2019
Q3 		$802K Buy
+5,168
New +$585K ﹤0.01% 2943
2018
Q4 		– Sell
-2,302
Closed -$1.63M – 3968
2018
Q3 		$1.63M Sell
2,302
-1,168
-34% -$734K ﹤0.01% 2346
2018
Q2 		$1.85M Buy
3,470
+1,867
+116% +$574K ﹤0.01% 2276
2018
Q1 		$180K Buy
+1,603
New +$541K ﹤0.01% 3346

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

D.E. Shaw & Co's SLDB Position: Q1 2026 in Review

D.E. Shaw & Co increased its Solid Biosciences (SLDB) stake by 0.07% in Q1 2026, buying an estimated $565 and bringing the position to 128,348 shares worth $924K. The position accounts for ﹤0.01% of the portfolio, ranked #3493.

D.E. Shaw & Co first reported a position in SLDB in Q1 2018 and has held it in 15 quarters since. The position peaked at $1.85M in Q2 2018. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

  • D.E. Shaw & Co held 128,348 shares of Solid Biosciences worth $924K as of Q1 2026.
  • D.E. Shaw & Co bought 88 Solid Biosciences shares in Q1 2026, an estimated $565.
  • Solid Biosciences made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3493 holding.
  • D.E. Shaw & Co first reported a position in Solid Biosciences in Q1 2018 and has held it in 15 quarters since.
  • D.E. Shaw & Co's Solid Biosciences position peaked at $1.85M in Q2 2018.
  • 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.